Our study demonstrates that the impact of genetic risk variants in PNPLA3 and TM6SF2 on liver fibrosis is essentially dependent on the presence of metabolic dysfunction or significant alcohol consumption. This evidence concerns the gene PNPLA3 and Hepatic fibrosis.